Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

24.48
BATS BZX Real-Time Price
As of 1:50pm ET
 +0.20 / +0.82%
Today’s Change
10.41
Today|||52-Week Range
29.38
-6.99%
Year-to-Date
3 Biotech Stocks to Buy in February
Feb 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close24.28
Today’s open24.31
Day’s range24.31 - 24.82
Volume7,206
Average volume (3 months)279,214
Market cap$1.1B
Dividend yield--
Data as of 1:50pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+13.46%
Earnings growth (this year)+227.78%
Earnings growth (next 5 years)--
Revenue growth (last year)+191.62%
P/E ratio24.7
Price/Sales20.55
Price/Book6.06

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.14-2.50%
SGYPSynergy Pharmaceutic...-0.20-3.30%
IPXLImpax Laboratories I...0.000.00%
EGRXEagle Pharmaceutical...-1.20-1.62%
Data as of 1:52pm ET, 02/21/2017

Financials

Next reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$27.8M
Annual profit (last year)-$17.6M
Net profit margin-63.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts


Search for Jobs